Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2

  1. Pritchard, K.I.
  2. Burris III, H.A.
  3. Ito, Y.
  4. Rugo, H.S.
  5. Dakhil, S.
  6. Hortobagyi, G.N.
  7. Campone, M.
  8. Csöszi, T.
  9. Baselga, J.
  10. Puttawibul, P.
  11. Piccart, M.
  12. Heng, D.
  13. Noguchi, S.
  14. Srimuninnimit, V.
  15. Bourgeois, H.
  16. Gonzalez Martin, A.
  17. Osborne, K.
  18. Panneerselvam, A.
  19. Taran, T.
  20. Sahmoud, T.
  21. Gnant, M.
Revue:
Clinical Breast Cancer

ISSN: 1938-0666,  1526-8209

Année de publication: 2013

Volumen: 13

Número: 6

Pages: 421-432.e8

Type: Article

DOI: 10.1016/J.CLBC.2013.08.011 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus